Proceedings of the National Academy of Sciences · 2013 · 115 citations · 36 references
MedicineMolecular BiologyOncologyMolecular OncologyOncogenesTumor ProgressionCancer Cell SignalingLung CancerMicrorna BiologyMicrorna-mediated RegulationOncogenic Signaling PathwaysSignal Transduction In CancerMet Receptor Tyrosine KinaseMet-targeted TherapyMicrorna In CancerMicrorna Regulation In CancerMicrorna TherapeuticsNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentTyrosine Kinase Receptors
In the past decade, we have observed exciting advances in lung cancer therapy, including the development of targeted therapies. However, additional strategies for early detection and tumor-based therapy are still essential in improving patient outcomes. EGF receptor (EGFR) and MET (the receptor tyrosine kinase for hepatocyte growth factors) are cell-surface tyrosine kinase receptors that have been implicated in diverse cellular processes and as regulators of several microRNAs (miRNAs), thus contributing to tumor progression. Here, we demonstrate a biological link between EGFR, MET, and the miRNA cluster 23a ~ 27a ~ 24-2. We show that miR-27a regulates MET, EGFR, and Sprouty2 in lung cancer. In addition, we identify both direct and indirect mechanisms by which miR-27a can regulate both MET and EGFR. Thus, we propose a mechanism for MET and EGFR axis regulation that may lead to the development of therapeutics in lung cancer.
36
The functions of animal microRNAs
Victor Ambros · Nature · 2004 · 10.8K citations
Large-scale analysis of the human and mouse transcriptomes
Andrew I. Su, M. Cooke, Keith A. Ching et al. · Proceedings of the National Academy of Sciences · 2002 · 1.5K citations